“Antitumor Activity of New Methylpyrazolotriazine and Pyrazolobenzotriazine Derivatives Tested on MCF-7, MDA-MB-231, and BT-474 Breast Cancer Cell Lines”. Voprosy Onkologii, vol. 72, no. 3, July 2026, p. OF-2446, https://doi.org/10.37469/0507-3758-2026-72-3-OF-2446.